Russell Investments Group Ltd. Buys 17,160 Shares of Guardian Pharmacy Services, Inc. $GRDN

Key Points

• Russell Investments Group Ltd. has increased its stake in Guardian Pharmacy Services by 23.4%, owning 90,401 shares valued at $1.92 million.
• Several other institutional investors have also recently adjusted their positions, with Wells Fargo & Company MN increasing its stake by a significant 353.7% in the fourth quarter.
• Wall Street analysts have rated Guardian Pharmacy Services with a consensus rating of "Buy" and a price target averaging $25.67.

Russell Investments Group Ltd. raised its stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 23.4% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 90,401 shares of the company's stock after acquiring an additional 17,160 shares during the period. Russell Investments Group Ltd. owned approximately 0.14% of Guardian Pharmacy Services worth $1,922,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Premier Fund Managers Ltd bought a new position in Guardian Pharmacy Services during the first quarter valued at approximately $435,000. Meeder Asset Management Inc. purchased a new stake in Guardian Pharmacy Services during the first quarter valued at approximately $88,000. Royce & Associates LP boosted its stake in shares of Guardian Pharmacy Services by 27.6% during the 1st quarter. Royce & Associates LP now owns 273,068 shares of the company's stock worth $5,805,000 after acquiring an additional 59,068 shares during the last quarter. New York State Common Retirement Fund grew its position in shares of Guardian Pharmacy Services by 16.1% during the 1st quarter. New York State Common Retirement Fund now owns 323,257 shares of the company's stock valued at $6,872,000 after acquiring an additional 44,709 shares during the period. Finally, Brown Advisory Inc. increased its stake in shares of Guardian Pharmacy Services by 0.6% in the 1st quarter. Brown Advisory Inc. now owns 1,602,824 shares of the company's stock worth $34,076,000 after purchasing an additional 8,870 shares in the last quarter.

Guardian Pharmacy Services Stock Up 0.5%

Guardian Pharmacy Services stock traded up $0.13 during mid-day trading on Monday, reaching $26.28. 373,775 shares of the company's stock traded hands, compared to its average volume of 262,308. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $26.91. The stock has a 50 day moving average of $22.03 and a two-hundred day moving average of $21.83. The company has a market cap of $1.66 billion and a price-to-earnings ratio of -17.29.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on GRDN. Raymond James Financial set a $28.00 price target on Guardian Pharmacy Services and gave the company an "outperform" rating in a report on Wednesday, May 14th. Truist Financial reaffirmed a "buy" rating and set a $28.00 price target (up previously from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Finally, Wall Street Zen upgraded Guardian Pharmacy Services from a "hold" rating to a "strong-buy" rating in a research report on Sunday, August 17th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $25.67.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.